Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.54 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.54 |
| ▸ | NPY2R | P49146 | 6/20 | 0.51 |
| ▸ | NPY4R | P50391 | 6/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.51 |
| ▸ | NPY1R | P25929 | 4/20 | 0.51 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30571139 | 0.87 | NPY2R (0.58) | OPRM1NTSR2NTSR1SORT1NPY2R | |
| SCHEMBL31307281 | 0.86 | SLC6A2 (0.58) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL29753383 | 0.86 | OPRM1 (0.57) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL30350851 | 0.86 | SLC6A2 (0.57) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL31575703 | 0.84 | NTSR1 (0.60) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL30752392 | 0.84 | SLC6A2 (0.71) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL30428981 | 0.84 | NTSR1 (0.59) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL31410882 | 0.84 | SLC6A2 (0.67) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL31410865 | 0.84 | SLC6A2 (0.64) | OPRM1SLC6A2NTSR2NTSR1SORT1 | |
| SCHEMBL31114471 | 0.84 | OPRM1 (0.63) | OPRM1SLC6A2NTSR2NTSR1SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2026-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | VIP, ARGLU1, PELP1 | OPRM1 467/4885SLC6A2 4333/4885NTSR2 872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.